Jessica advises life sciences companies on domestic and international patent prosecution, particularly in the fields of molecular and cell biology, developmental biology, neurobiology, genetics, and genomics. Jessica also advises on patent landscape analyses, freedom-to-operate analyses, portfolio lifecycle management, licensing, and IP due diligence. Her practice spans a wide variety of life sciences technologies, with particular emphasis on gene therapy, gene-editing technologies, and DNA sequencing, as well as cell therapies, antibodies, and other biologics.

Prior to joining Fenwick, Jessica was an associate at an AmLaw 100 firm. She has a strong research background, including a Ph.D. in Molecular and Cell Biology from the University of California at Berkeley and post-doctoral positions at the Howard Hughes Medical Institute’s Janelia Research Campus and the Institut de Biologie du Développement Marseille. Her research focused on the evolution of the dorsoventral axis in insect development and the evolutionary genetics and neurobiology of courtship behavior in fruit flies. She has experience in quantitative genetics, genomics, genetic engineering, next-generation sequencing, neurobiology, and developmental biology.